Cargando…
Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies
Autores principales: | Berghmans, Thierry, Cadranel, Jacques, Grigoriu, Bogdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655242/ https://www.ncbi.nlm.nih.gov/pubmed/34901075 http://dx.doi.org/10.3389/fmed.2021.761078 |
Ejemplares similares
-
Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders
por: Coureau, Michelle, et al.
Publicado: (2020) -
Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung Cancer
por: Amrane, Karim, et al.
Publicado: (2021) -
New drugs in thoracic oncology: needs and knowledge – an online ERS Lung Cancer Assembly survey
por: Berghmans, Thierry, et al.
Publicado: (2018) -
Advances in target therapy in lung cancer
por: Sculier, Jean-Paul, et al.
Publicado: (2015) -
Oligometastatic non-small cell lung cancer: from biology to clinical practice
por: Infante, Maurizio V., et al.
Publicado: (2021)